Janus Henderson Group PLC Arbutus Biopharma Corp Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 60,900 shares of ABUS stock, worth $200,970. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,900Holding current value
$200,970% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
162Shares Held
102MCall Options Held
2.15MPut Options Held
358K-
Morgan Stanley New York, NY21.7MShares$71.6 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$42.5 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$29.6 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$28.8 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $495M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...